gastroenteritis semaglutide Frontiers FDA Grants Accelerated Approval of

Gallbladder issues (gallstones, inflammation)

Ships from Atlanta, GA

Discontinuation should be considered when: Vomiting is severe, persistent, and unresponsive to management strategies Symptoms significantly impair quality of life or ability to function Dehydration or malnutrition develops Complications such as pancreatitis are suspected or confirmed (Ozempic should not be restarted if pancreatitis is confirmed) [1] [2] The patient wishes to discontinue despite medical advice to continue Alternative GLP-1 receptor agonists with different pharmacokinetic profiles may be better tolerated if Ozempic is discontinued

A review of recent research and development on GLP-1 receptor agonists-sustained-release microspheres

Cell 182 , 12711283 (2020)